Structures by: Abuthahir S. S.
Total: 12
2-(4-{2-[(2-Oxo-2<i>H</i>-chromen-4-yl)oxy]acetyl}piperazin-1-yl)acetamide
C17H19N3O5
Acta Crystallographica Section E (2019) 75, 4 482-488
a=8.5260(3)Å b=8.8415(3)Å c=11.9462(4)Å
α=88.660(2)° β=69.568(2)° γ=70.724(2)°
<i>N</i>-(2,4-Dimethoxybenzyl)-2-[(2-oxo-2<i>H</i>-chromen-4-yl)oxy]acetamide
C20H19NO6
Acta Crystallographica Section E (2019) 75, 4 482-488
a=7.2779(2)Å b=8.5759(3)Å c=14.4099(5)Å
α=90° β=93.796(5)° γ=90°
6-(4-Chlorophenyl)-6a-nitro-6a,6b,8,9,10,12a-hexahydro-6<i>H</i>,7<i>H</i>-spiro[chromeno[3,4-<i>a</i>]indolizine-12,11'-indeno[1,2-<i>b</i>]quinoxaline]
C35H27ClN4O3
Acta Crystallographica Section E (2019) 75, 2 255-259
a=14.18800(10)Å b=23.4450(3)Å c=18.3710(2)Å
α=90° β=104.541(2)° γ=90°
6'-(4-Chlorophenyl)-6a'-nitro-6a',6b',7',9',10',12a'-hexahydro-2<i>H</i>,6'<i>H</i>,8'<i>H</i>-spiro[acenaphthylene-1,12'-chromeno[3,4-<i>a</i>]indolizin]-2-one
C32H25ClN2O4
Acta Crystallographica Section E (2019) 75, 2 218-222
a=10.6777(4)Å b=11.6095(4)Å c=12.6037(8)Å
α=98.383(3)° β=105.378(3)° γ=115.522(2)°
6'-(4-Methoxyphenyl)-6a'-nitro-6a',6b',7',9',10',12a'-hexahydro-2<i>H</i>,6'<i>H</i>,8'<i>H</i>-spiro[acenaphthylene-1,12'-chromeno[3,4-<i>a</i>]indolizin]-2-one
C33H28N2O5
Acta Crystallographica Section E (2019) 75, 2 218-222
a=19.8942(2)Å b=13.6097(7)Å c=20.78220(10)Å
α=90° β=107.268(3)° γ=90°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl benzoate
C20H19N3O4S
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=6.75590(10)Å b=16.9258(2)Å c=19.0611(3)Å
α=110.4470(10)° β=96.854(2)° γ=93.3700(10)°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl isobutyrate 0.25-hydrate
C17H21N3O4S,0.25(H2O)
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=6.78020(10)Å b=17.2671(4)Å c=17.3089(4)Å
α=108.2240(10)° β=99.0840(10)° γ=96.7200(10)°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl propionate
C16H19N3O4S
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=11.4150(3)Å b=12.4021(3)Å c=13.2305(3)Å
α=71.9820(10)° β=89.8290(10)° γ=83.1140(10)°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl cinnamate chloroform hemisolvate
C22H21N3O4S,0.5(CHCl3)
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=10.74270(10)Å b=11.0828(2)Å c=20.8969(3)Å
α=93.1860(10)° β=103.945(4)° γ=98.489(2)°
8-Amino-6-methyl-3,4-diphenyl-1<i>H</i>-isochromen-1-one
C22H17NO2
Acta Crystallographica Section E (2019) 75, 8 1117-1122
a=9.1652(3)Å b=16.9764(6)Å c=10.9687(4)Å
α=90° β=91.1560(10)° γ=90°
2-[(2-Oxo-2<i>H</i>-chromen-4-yl)oxy]acetic acid dimethyl sulfoxide monosolvate
C11H8O5,C2H6OS
Acta Crystallographica Section E (2019) 75, 8 1123-1127
a=23.1461(12)Å b=8.2631(4)Å c=14.6374(8)Å
α=90° β=97.687(4)° γ=90°
8-Amino-3,4-diethyl-6-methyl-1<i>H</i>-isochromen-1-one
C14H17NO2
Acta Crystallographica Section E (2019) 75, 8 1117-1122
a=10.4844(8)Å b=26.562(2)Å c=9.3651(6)Å
α=90° β=105.367(3)° γ=90°